Atraumatic processing that is safe, fast, and simple, providing superior cell viability, precision and control

Simple and fast morsalization of full thickness skin biopsy with the TissueMil System.

  • • Small full thickness elliptical skin biopsy
    • Immediate closure with sutures
    • No open wound requiring dressing changes
    • No pain

  • • Morsalization of biopsy
    • Closed aseptic system
    • Rapid: <15 minutes
    • Automated process
    • High cell viability

  • • Morsels are immediately spread over wound surface
    • Gold standard: Healthy full thickness skin micrografts

Atraumatic cutting process results in micrografts that retain native architecture and high cell viability.

  • high-quality micrografts

  • excellent histology

  • high viability
    (70% - 90% live cells)

OUR TECHNOLOGY.

Unique cutting system in an aqueous medium enables to cut tissue atraumatically preserving native tissue architecture and cell viability.

An aseptic sterile chamber contains a cutting mechanism designed to slice the tissue morsels atraumatically to preserve their native architecture.

A continuous circulating movement of liquid and tissue though the cutting mechanism is designed to slice the tissue into progressively smaller size micrografts until desired size is achieved.

POSITIONED FOR SUCCESS.

Manufacturing process verification & validation completed

Transferred to ISO 13485:2016 certified manufacturing facility

Completed clinical study to assess the safety and efficacy of TissueMil device to treat hard to heal wounds unresponsive to treatment for a minimum of 30 days

Leadership

  • Dr. Thomas Davenport

    CO-FOUNDER

    Dr. Davenport has been a partner at Long Island Plastic Surgical Group since 2006. He  received his MD degree from Yale University and completed both his residency in General Surgery and fellowship in Plastic Surgery in the Harvard University Program at the Massachusetts General Hospital. He completed specialty training as a fellow at Memorial Sloan-Kettering Cancer Center and specializes in treating complex wound problems, including wound care and burn reconstruction.

  • Alain Klapholz

    CO-FOUNDER & COO

    Mr. Klapholz received his B.A. in economics from Yeshiva University and his M.B.A. in finance from the New York University – Leonard N. Stern School of Business. Over the past 26 years Mr. Klapholz has served at a number of medical device companies collaborating on product development, business development and finance, successfully leading several products through the FDA approval process.

Contact us.

info@tissuemilltech.com